The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The index has shown a price loss of -44.16% this year. Over the last six months, there has been a stronger performance of -31.76%. The price of PCRX fallen by 7.35% during the last 30 days period. For the last 5-days stocks have slided -4.99%.
The market performance of Pacira BioSciences Inc has been somewhat unstable. Over the past year, the company’s stock achieved a high of $35.95 on 01/08/24, with the lowest value for the same timeframe being $11.16, recorded on 08/13/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of PCRX Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Pacira BioSciences Inc’s current trading price is -45.84% away from its 52-week high, while its distance from the 52-week low is 74.40%. The stock’s price range for this period has been between $11.16 and $35.95. The Healthcare sector company’s shares saw a trading volume of about 0.27 million for the day, which was lower than the average daily volume of 0.73 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Pacira BioSciences Inc (PCRX) has experienced a quarterly rise of 35.44% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 869.91M and boasts a workforce of 712 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 16.35, with a change in price of -1.79. Similarly, Pacira BioSciences Inc recorded 987,873 in trading volume during the last 100 days, posting a change of -8.42%.
PCRX’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for PCRX stands at 0.86. Similarly, the long-term debt-to-equity ratio is also 0.58.
PCRX Stock Stochastic Average
As of today, the raw stochastic average of Pacira BioSciences Inc over the past 50 days is 78.51%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 77.00%. Additionally, the Stochastic %K and %D values for the company were 70.86% and 71.37%, respectively, over the past 20 days.
